| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 4 |
| 1 | SILDENAFIL CITRATE | 4 |
| 2 | ECULIZUMAB | 3 |
| 3 | FUROSEMIDE | 3 |
| 4 | SILDENAFIL | 3 |
| 5 | SILDENAFIL POWDER, | 3 |
| 6 | ALBUTEROL SULFATE | 2 |
| 7 | ALENDRONATE SODIUM | 2 |
| 8 | ALGLUCOSIDASE ALFA | 2 |
| 9 | AMBRISENTAN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 1 | ALGLUCOSIDASE ALFA | 2 | 0.0008 |
| 2 | GALSULFASE | 2 | 0.0005 |
| 3 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 4 | CALCIUM CHLORIDE INJECTION | 1 | 0.0003 |
| 5 | LETERMOVIR | 1 | 0.0003 |
| 6 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| 7 | TROFINETIDE | 1 | 0.0001 |
| 8 | TOBRAMYCIN | 2 | 0.0001 |
| 9 | SILDENAFIL POWDER, | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Aminoglycoside Antibacterial [EPC] | 2 | 0.0000 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 4 | 0.0000 |